Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients
Status:
Recruiting
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
In this study, patients will be offered two Pressurized Intraperitoneal Aerosol Chemotherapy
(PIPAC) treatments with oxaliplatin after primary resection and standard adjuvant
chemotherapy (if indicated) for colon cancer. Furthermore, the study will explore, whether it
is possible to find free intraperitoneal tumor cells (FITC) after resection and adjuvant
chemotherapy for colon cancer.